C
Charles River Laboratories International
Research models, and outsourced preclinical services for the accelerated r&d of drugs
About Charles River Laboratories International
Charles River Laboratories, accessible via criver.com, is a pioneering company in the life sciences sector, dedicated to advancing the discovery, development, and safe manufacture of novel drugs and therapies. With a legacy of 70 years, Charles River has been at the forefront of innovation, particularly in the responsible advancement of alternative methods in animal research, focusing on replacement, reduction, and refinement.
The company operates in the biopharmaceutical market, serving a diverse clientele that includes pharmaceutical and biotechnology companies, government agencies, and academic institutions. Charles River offers a broad range of services, from basic research to comprehensive solutions for antibody discovery and cell therapy manufacturing. Their services are designed to accelerate the development of biopharmaceuticals from concept to cure, ensuring compliance with current Good Manufacturing Practices (CGMP).
Charles River's business model revolves around providing flexible and scalable testing platforms and manufacturing services. These platforms can be deployed at client facilities, satellite labs, or within Charles River's own extensive network of over 100 facilities in more than 20 countries. This flexibility allows clients to expedite their research and development processes efficiently.
Revenue generation for Charles River comes from offering specialized contract research and manufacturing services. These services include biologics contract manufacturing, antibody discovery, and cell therapy manufacturing, all tailored to meet the unique needs of their clients. Additionally, the company invests heavily in environmental, social, and governance (ESG) strategies, aiming to achieve 100% renewable electricity globally by 2030, which underscores their commitment to sustainability.
In summary, Charles River Laboratories is a key player in the life sciences industry, providing essential services that support the development of new drugs and therapies, with a strong emphasis on innovation, flexibility, and sustainability.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2000
- Employees
- 10,608
- Open positions
- 172
- Dealroom signal
- 27.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology, Health Platform
- Sector
- Biotechnology, Drug Development, Horizon Europe
- Business model
- Manufacturing
- Client focus
- B2B
- Investment activity
- 39 companies, latest Jan 2026
- Capital deployed
- $303M
- Preferred round
- ACQUISITION
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Dec 2024 | $0 | — | Undisclosed | ↗ |
| GRANTOther financing | Jun 2024 | $1.3M | — | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Charles River Laboratories International is 230K monthly website visits, up 27.8% over the last three months. Charles River Laboratories International's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
PathoQuestParis, FrancePathoQuest is a biotechnology company identifying pathogens through High Throughput Sequencing (HTS).
$66Mvaluation
DeciphexDublin, IrelandTransforming Pathology using Tailored Workflows and Artificial Intelligence
$66Mvaluation
ATEM Structural DiscoveryRemscheid, Germany3D strucutres for rational drug design
→
Ability BiologicsMontreal, CanadaDeveloping innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and autoimmune diseases
$60Mvaluation
Vernal BiosciencesColchester, United StatesManufacturer of high purity mRNA for research and clinical use
$105Mvaluation
Wheeler BioOklahoma City, United StatesBy bringing together biologics drug innovators, discovery CROs, and CDMOs accelerating the translation of therapeutic innovation to clinical impact
$140Mvaluation
SAMDI TechChicago, United States
$63Mvaluation
iVexSolLexington, United StatesiVexSol Inc. | Intelligent Vector Solutions™
$95Mvaluation
Explora BiolabsSan Diego, United States
$285Mvaluation
bit.bioCambridge, United KingdomDeveloping a scalable technology platform capable of producing consistent batches of every human cell
$200Mvaluation
Vigene Biosciences Inc.Rockville, United StatesVigene Biosciences - Excellence in Gene Delivery
$293Mvaluation
RetrogenixStockport, United Kingdom
$46Mvaluation
Charles River Laboratories International in the Wilmington ecosystem
The Charles River Laboratories International office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Institutes of Health
Series B and later1 investor entered at this stage
- TITinicum
Other known investors4 additional known investors
Avista Healthcare Partners- EPEuropean Equity Partners
EW Healthcare Partners
New Leaf Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Charles River Laboratories International on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Charles River Laboratories International’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








